Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia
Authors:
- 30 November 2008
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 90 (5) , 1864-1868
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Superiority of Newly Developed Vaginal Suppositories Over Vaginal Use of Commercial Bromocriptine Tablets: A Randomized Controlled Clinical TrialReproductive Sciences, 2007
- Evaluation of a novel vaginal bromocriptine mesylate formulation: A pilot studyFertility and Sterility, 2005
- Formulation and evaluation of diclofenac sodium buccoadhesive discsInternational Journal of Pharmaceutics, 2004
- Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillersIl Farmaco, 2004
- Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studiesInternational Journal of Pharmaceutics, 2003
- In-vitro and in-vivo evaluation of a matrix-controlled bromocriptine mesilate-releasing vaginal ringJournal of Pharmacy and Pharmacology, 2001
- The scope and potential of vaginal drug deliveryPharmaceutical Science & Technology Today, 2000
- Plasma prolactin measurement is not indicated in women in the routine investigation of uncomplicated infertility.Human Fertility, 1999
- Novel vaginal drug release applicationsAdvanced Drug Delivery Reviews, 1993
- Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemiaFertility and Sterility, 1989